← Human Trials & Peer-Reviewed Studies

[Effect of growth hormone combined with nutritional support on postoperative fatigue syndrome in patients after abdominal operations].

Plain-language guide to PMID 17236593 (2006): randomized controlled trial of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 48 patients.

Key Facts

PMID
17236593
Journal
Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition
Year
2006
Study type
Randomized Controlled Trial
Authors
Zhang MM et al. (5 authors)

What This Study Did, in Plain Language

What Was Tested

Researchers studied Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in this randomized controlled trial publication.

Who Took Part

The abstract describes 48 patients taking part.

PubMed indexes the participants as teenagers, young adults, adults, middle-aged adults and older adults, both men and women.

Informed consent was obtained from each prospective subject.

A total of 48 consecutive patients undergoing the elective abdominal operations were randomly divided into the rhGH group and the placebo group.

How the Study Was Run

The design is described as randomized and placebo-controlled.

The patients were allocated by chance, so the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) group and the comparison group should start out alike.

A placebo (an inactive look-alike) gave the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) group a baseline to be compared against.

The two groups had similar nutritional intakes.

Plasma proteins, fatigue (Christensen score) and body weight were investigated before and after operations.

Nitrogen balance was measured from day 3 to day 9 after operation.

What Was Measured

The subject headings attached to it are Abdomen, Blood Glucose, Fatigue, Fibronectins, Human Growth Hormone, Nitrogen and Nutritional Support.

What This Means in Plain Language

The paper is a randomized and placebo-controlled study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 48 patients.

Results are reported in around 6 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2006 (Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition), a journal based in China.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.

Our Notes on the Compound

Exogenous HGH, sermorelin & older GHRPs (why they're passed over): Constant levels suppress the body's own GHRH, raise somatostatin and dull pituitary response.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.